Tag: CMRX

  • Trader’s Recap: Canadian Solar Inc. (NASDAQ:CSIQ), Netflix, Inc. (NASDAQ:NFLX), JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), Gogo Inc. (NASDAQ:GOGO), Chimerix Inc. (NASDAQ:CMRX)

    TheStreet cut shares of Canadian Solar (NASDAQ:CSIQ) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. Canadian Solar Inc. (NASDAQ:CSIQ) net profit margin is 1.90% and weekly performance is -10.88%. On last trading day company shares ended up $24.00. Analysts mean target price for the company is $46.14. Canadian Solar Inc. (NASDAQ:CSIQ) distance from 50-day simple moving average (SMA50) is -18.04%.

    The ever so convenient online movie and TV subscription service Netflix, Inc. (NASDAQ:NFLX) has announced they will expand its services. This morning Netflix announced that 6 more European countries will test the service in a strategic way that is set to challenge its competitors. The countries that are being tested include France and Germany. Netflix, Inc. (NASDAQ:NFLX) shares advanced 5.09% in last trading session and ended the day on $390.60. NFLX gross Margin is 30.20% and its return on assets is 3.10%.Netflix, Inc. (NASDAQ:NFLX) quarterly performance is -10.20%.

    JA Solar Holdings (NASDAQ:JASO) stock is gaining Wednesday, pulled higher by positive earnings results from fellow alternative energy developer Trina Solar (TSL). JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) shares moved up 5.18% in last trading session and was closed at $9.75, while trading in range of $9.40 – $9.88. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) year to date (YTD) performance is 6.32%.

    Gogo Inc. (NASDAQ:GOGO) has appointed Shuaib Shahid as the new Manager, Service Sales for its business aviation group. The Business aviation group of Gogo is popularly known as Aircell. Gogo Inc. (NASDAQ:GOGO) ended the last trading day at $15.25. Company weekly volatility is calculated as 6.77% and price to cash ratio as 5.91.Gogo Inc. (NASDAQ:GOGO) showed a positive weekly performance of 13.64%.

    Durham-based Chimerix Inc. (NASDAQ:CMRX) plans to use $60 million of the proceeds of an upcoming stock sale to pay for a pilot study to test its lead experimental drug against adenovirus, among other studies, according to a recent regulatory filing. Chimerix Inc. (NASDAQ:CMRX) weekly performance is -2.70%. On last trading day company shares ended up $16.20. Analysts mean target price for the company is $31.67. Chimerix Inc. (NASDAQ:CMRX) distance from 50-day simple moving average (SMA50) is -22.34%.